Cargando…
Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
BACKGROUND: Persons with high-grade glioma face both neurological and cancer-related symptoms from the tumor itself and its treatment affecting their daily lives. Survival alone is not an adequate outcome, the quality of the survivorship experience needs to be regarded with equal importance. Patient...
Autores principales: | Rosenlund, Lena, Degsell, Eskil, Jakola, Asgeir Store |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711557/ https://www.ncbi.nlm.nih.gov/pubmed/31692481 http://dx.doi.org/10.2147/PROM.S179313 |
Ejemplares similares
-
Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022) -
WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022) -
DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021) -
Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
por: Buvarp, Dongni, et al.
Publicado: (2021) -
Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
por: Carstam, Louise, et al.
Publicado: (2019)